![]() |
市場調査レポート
商品コード
1701929
下大静脈(IVC)フィルター市場:製品別、材料別、用途別、エンドユーザー別、地域別、2024-2032年Inferior Vena Cava Filter Market by Product, Material, Application (Treatment Venous Thromboembolism, Prevent Pulmonary Embolism, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032 |
||||||
カスタマイズ可能
|
下大静脈(IVC)フィルター市場:製品別、材料別、用途別、エンドユーザー別、地域別、2024-2032年 |
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2~3営業日
|
下大静脈(IVC)フィルターの世界市場規模は2024年に7億6,900万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに14億900万米ドルに達し、2025年から2033年の間に7%の成長率(CAGR)を示すと予測しています。深部静脈血栓症(DVT)および肺塞栓症(PE)の有病率の増加、疾患のリスクと結果に関する消費者の意識の高まり、低侵襲手術への嗜好の高まりは、市場を推進する主な要因の一部です。
下大静脈(IVC)フィルターは、下半身から肺への血栓の移動を防ぎ、肺塞栓症のリスクを低減するように設計された医療機器です。金属または合成材料で製造された小型のかご状の構造物です。下半身から心臓へ脱酸素血液を送る下大静脈に挿入します。血栓を捕捉し、それが肺に到達するのを防ぐことによって、物理的な障壁として機能します。
現在、血栓発生のリスクが高い患者の間でIVCフィルターの採用が増加していることが、市場の成長に寄与しています。これとは別に、医療プロバイダーによる有利な償還政策を理由にIVCフィルターの利用が増加していることも、市場の成長を後押ししています。さらに、静脈血栓塞栓症になりやすい高齢者の間でIVFフィルターの採用が増加していることも、市場の成長を後押ししています。さらに、世界中の大衆の間で低侵襲手術への嗜好が高まっているため、IVCフィルターの需要が増加しており、市場にプラスの影響を与えています。さらに、医療インフラの改善による治療ソリューションの採用の増加が、市場の成長を強化しています。
深部静脈血栓症(DVT)および肺塞栓症(PE)の有病率の上昇
世界中の大衆の間で深部静脈血栓症(DVT)と肺塞栓症(PE)の有病率が増加しているため、IVCフィルターの需要が増加しています。深部静脈血栓症は通常、深部静脈(多くは脚)に血栓が形成されることで発症します。さらに、これらの血栓がほぐれて肺に移動すると、肺塞栓症として知られる生命を脅かす状態を引き起こす可能性があります。座りがちな生活、肥満、不適切な運動、その他の生活習慣に関連する問題により、DVTやPEに直面する人が増えています。さらに、高齢化社会ではDVTを開発する可能性が高まっています。さらに医療プロバイダーは、PEとそれに関連する罹患率や死亡率の発生を抑えるため、リスクの高い患者の予防策としてIVCフィルターの採用を増やしています。
疾患のリスクと結果に関する消費者の意識の高まり
医療従事者や一般消費者の間でDVTやPEのリスクや結果に対する意識が高まっているため、IVCフィルターの需要が増加しています。
各国の行政機関は、静脈血栓塞栓症の予防に焦点を当てた啓蒙活動やキャンペーンを実施し、教育的イニシアチブをとることで、IVCフィルターの採用を奨励しています。さらに、診断能力の急速な進歩により、DVTやPEの症例がより正確かつタイムリーに発見されるようになり、患者の予後が向上しています。さらに、早期診断により、医療専門家はIVCフィルター留置が有益な患者を特定することができます。肺塞栓症予防のための信頼性が高く効果的なソリューションとしてIVCフィルターの利用が増加していることが、市場の成長に寄与しています。
IVCフィルター技術の進歩
さまざまなメーカーが、製品の安全性と有効性を向上させるために、IVCフィルター技術を急速に進化させています。また、肺塞栓症のリスクが落ち着いた時点で取り外すことができる回収型IVCフィルターの導入が増加しています。このような回収可能なフィルターは、患者を効果的に管理するための柔軟性と選択肢を医療専門家に提供するものであり、市場の見通しをポジティブなものにしています。さらに、フィルターの設計や材料におけるさまざまな技術的進歩は、生体適合性を高め、有害反応や長期合併症のリスクを低減するのに役立っています。これとは別に、IVCフィルターはその強化された有効性により、適切な症例への採用率が上昇しています。
The global inferior vena cava (IVC) filter market size reached USD 769.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,409.0 Million by 2033, exhibiting a growth rate (CAGR) of 7% during 2025-2033. The growing prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE), rising consumer awareness about the risks and consequences of diseases, and increasing preference for minimally invasive surgical procedures are some of the major factors propelling the market.
An inferior vena cava (IVC) filter is a medical device that is designed to prevent the migration of blood clots from the lower body to the lungs and reduce the risk of pulmonary embolism. It is a small and cage-like structure that is manufactured from metal or synthetic materials. It is inserted into the inferior vena cava vein that carries deoxygenated blood from the lower body to the heart. It acts as a physical barrier by trapping blood clots and preventing them from reaching the lungs.
At present, the increasing adoption of IVC filters among patients who are at high risk of developing blood clots is contributing to the growth of the market. Apart from this, the rising utilization of IVC filters on account of favorable reimbursement policies by healthcare providers is propelling the growth of the market. Moreover, the increasing adoption of IVF filters among the geriatric population, as they are more prone to venous thromboembolism, is bolstering the growth of the market. Additionally, the growing demand for IVC filters due to the increasing preference for minimally invasive surgical procedures among the masses around the world is positively influencing the market. Furthermore, the rising adoption of medical treatment solutions due to the improving healthcare infrastructure is strengthening the growth of the market.
Rising prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE)
There is a rise in the demand for IVC filters due to the increasing prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE) among the masses across the globe. Deep vein thrombosis usually occurs when blood clots form in deep veins, often in the legs. Moreover, if these clots break loose and travel to the lungs, then they can cause a life-threatening condition known as pulmonary embolism. People are increasingly facing DVT and PE cases due to sedentary lifestyles, obesity, improper physical activity, and other lifestyle-related issues. Additionally, there is an increased chance of the development of DVT among the geriatric aging population. Furthermore, healthcare providers are increasingly adopting IVC filters as a preventive measure for high-risk patients to reduce the occurrence of PE and its associated morbidity and mortality.
Increasing consumer awareness about the risks and consequences of diseases
There is an increase in the demand for IVC filters due to the rising awareness about the risks and consequences of DVT and PE among healthcare professionals and the general population.
Governing agencies of various countries are encouraging the adoption of IVC filters by spreading awareness, organizing campaigns, and taking educational initiatives to focus on venous thromboembolism prevention. Moreover, rapid advancements in diagnostic capabilities allow more accurate and timely detection of DVT and PE cases that enhances patient outcomes. In addition, early diagnosis allows healthcare professionals to identify individuals who could benefit from IVC filter placement. The rising utilization of IVC filters to provide a reliable and effective solution for preventing pulmonary embolism is contributing to the growth of the market.
Advancements in IVC filter technology
Various manufacturers are rapidly advancing IVC filter technology to provide improved safety and efficacy of the product. In addition, the rising introduction of retrievable IVC filters, which can be removed once the risk of pulmonary embolism has settled. These retrievable filters provide healthcare professionals with more flexibility and options for managing patients effectively, which is offering a positive market outlook. Additionally, various technological advancements in filter design and materials assist in enhancing biocompatibility and reducing the risk of adverse reactions and long-term complications. Apart from this, the rising adoption rates of IVC filters for appropriate cases due to their enhanced effectiveness.
Retrievable IVC filter represents the largest market segment
Retrievable IVC filters are medical devices that are designed to be implanted temporarily in patients at high risk of pulmonary embolism. They can be removed once the risk of clot migration has subsided or when the condition of the patient is improved. In addition, the retrievable IVC filter placement procedure is minimally invasive and typically performed by an interventional radiologist. The rising adoption of retrievable IVC filters, as they offer flexibility to healthcare providers in treatment options, is propelling the growth of the market.
Non-ferromagnetic material accounts for the majority of the market share
Non-ferromagnetic materials are those that do not contain iron and do not exhibit magnetic properties. They are used to construct filter devices and offer enhanced biocompatibility. They can withstand the physiological environment within the human body without causing adverse reactions. In addition, they are widely used in medical settings where the presence of magnetic materials could interfere with imaging techniques, such as magnetic resonance imaging (MRI). Non-ferromagnetic materials are utilized in the construction of IVC filters that allow patients to undergo MRI scans without any concerns about potential complications or distortions in the images.
Treatment venous thromboembolism (VTE) holds the biggest market share
In the treatment venous thromboembolism (VTE), the IVC filters are placed in the inferior vena cava that carries deoxygenated blood from the lower body to the heart, to trap blood clots and prevent their migration to the lungs. They assist in reducing the risk of pulmonary embolism and its potential consequences in the body. They also provide an additional layer of protection against blood clot migration in high-risk patients. In line with this, VTE treatment provides enhanced patient outcomes and improved overall safety in managing VTE cases.
Hospitals dominate the market share
Hospitals are the primary end-users of IVC filters, as they provide enhanced treatment options to patients with various medical conditions, such as those at high risk of venous thromboembolism (VTE). In hospitals, IVC filters are widely utilized in patients undergoing surgical procedures or those admitted for trauma or critical care, and individuals with known risk factors for developing deep vein thrombosis (DVT) or pulmonary embolism (PE). In addition, hospitals are equipped with advanced medical technologies and experienced healthcare professionals that benefit in managing VTE cases effectively. Interventional radiologists or vascular surgeons often perform the minimally invasive procedure of inserting IVC filters in hospital settings.
North America exhibits a clear dominance, accounting for the largest inferior vena cava (IVC) filter market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to the presence of well-established healthcare infrastructure and facilities. In addition, the rising prevalence of obesity among individuals is contributing to the growth of the market in the region. Apart from this, the increasing utilization of IVC filters as a preventive measure among patients is supporting the growth of the market. In line with this, the rising adoption of IVC filers due to favorable regulatory framework and reimbursement policies is bolstering the growth of the market in the North America region.
Key players in the industry are investing in research and development (R&D) activities to improve the design, materials, and safety features of IVC filters. In line with this, they are developing retrievable filters, enhancing the biocompatibility of products, and exploring innovative filter designs to reduce complications and enhance patient outcomes. Apart from this, many companies are launching new IVC filter products or introducing upgraded versions of their existing products to address specific clinical needs. They are also conducting clinical trials and research studies to gather more data on the safety and efficacy of their IVC filter products. In addition, major manufacturers are working to address safety concerns related to IVC filters, such as filter migration, fracture, and perforation.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report